by admin_63069 | Mar 10, 2025 | News You Can Use
Clearance of all visible prostate lesions at 6 months in five treated patients.
by admin_63069 | Mar 3, 2025 | News You Can Use
Advancing prostate cancer science through clinical trials and powerful data
by admin_63069 | Feb 24, 2025 | News You Can Use
Risk-benefit and individualized treatment
by admin_63069 | Feb 17, 2025 | News You Can Use
Understanding temporal fluctuations in prostate cancer after external radiotherapy
by admin_63069 | Feb 10, 2025 | News You Can Use
Early data has not demonstrated any increased risk of prostate cancer recurrence or progression in men using testosterone replacement therapy after prostate cancer.
by admin_63069 | Feb 3, 2025 | News You Can Use
It is important to consider disease volume, whether presentation with mCSPC is de novo, presence of comorbid conditions, and eligibility for docetaxel chemotherapy treatment.
